US8357713 — Compounds and compositions and methods of use
Method of Use · Assigned to Ardea Biociences Inc · Expires 2029-12-22 · 4y remaining
What this patent protects
This patent protects compounds and methods of using them to modulate blood uric acid levels and treat or prevent disorders related to uric acid.
USPTO Abstract
Described herein are compounds useful in the modulation of blood uric acid levels, formulations containing them and methods of using them. In some embodiments, the compounds described herein are used in the treatment or prevention of disorders related to aberrant levels of uric acid.
Drugs covered by this patent
- Aloprim (ALLOPURINOL) · Casper Pharma Llc
- Zurampic (LESINURAD) · Ironwood Pharms Inc
FDA Patent Use Codes
When a patent is method-of-use, FDA lists it once per applicable indication ("U-code"). Each U-code carves out a specific therapeutic use that generic filers must either license or design around.
| Code | Description | Drug |
|---|---|---|
U-2104 |
— | Aloprim |
U-1801 |
— | Zurampic |
U-2104 |
— | Aloprim |
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.